Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS
· Real-Time Price · USD
8.16
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM
Regulus Therapeutics Revenue
Regulus Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Regulus Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
34
Market Cap
564.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | -100.00% |
| Dec 31, 2020 | 10.01M | +46.46% |
| Dec 31, 2019 | 6.83M | +9388.89% |
| Dec 31, 2018 | 72K | n/a |
| Dec 31, 2017 | 72K | -93.97% |
| Dec 31, 2016 | 1.19M | -94.25% |
| Dec 31, 2015 | 20.76M | +170.69% |
| Dec 31, 2014 | 7.67M | -60.81% |
| Dec 31, 2013 | 19.57M | +54.09% |
| Dec 31, 2012 | 12.7M | -7.90% |
| Dec 31, 2011 | 13.79M | +60.32% |
| Dec 31, 2010 | 8.6M | n/a |